Ahlén, G
Holmström, F
Gibbs, A
Alheim, M
Frelin, L
Article History
Received: 26 December 2013
Revised: 18 March 2014
Accepted: 14 April 2014
First Online: 29 May 2014
Competing interests
: LF owns patent/patents pending for HCV-transgenic mouse models and HCV therapeutics. The remaining authors declare no conflict of interest.